News Sentiment

BTAI sentiment intelligence

BioXcel Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 49 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 0.82 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

84/100 classification confidence.

Company focus 49

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-40.8% over one week, -28.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

BioXcel Therapeutics (BTAI) Registration Filing Summary

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 84/100 classification
One-week reaction -40.8% Price reacting lower
Trend fit Trend inactive -28.3% over four weeks
Fair value -96.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 10
Neutral 28
Negative 11

Relevance

Why the article matched

Direct first
Direct company coverage 49
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 11
Market source 7
TradingView 5
Investing.com 4
Quartr 3
Finviz 2
Moomoo 2
TradingKey 2

Event Lens

What the news is about

Classified themes
Market update 34
Earnings 10
Balance sheet 1
Deals and strategy 1
Regulatory and legal 1
Guidance 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-49 of 49